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Objective: MicroRNAs (miRNAs) play an integral role in maintaining beta cell function and identity. Deciphering their targets and precise role,
however, remains challenging. In this study, we aimed to identify miRNAs and their downstream targets involved in the regeneration of islet beta
cells following partial pancreatectomy in mice.
Methods: RNA from laser capture microdissected (LCM) islets of partially pancreatectomized and sham-operated mice were proﬁled with
microarrays to identify putative miRNAs implicated in beta cell regeneration. Altered expression of the selected miRNAs, including miR-132, was
veriﬁed by RT-PCR. Potential targets of miR-132 were selected through bioinformatic data mining. Predicted miR-132 targets were validated for
their changed RNA, protein expression levels, and signaling upon miR-132 knockdown and/or overexpression in mouse MIN6 and human EndoC-
bH1 insulinoma cells. The ability of miR-132 to foster beta cell proliferation in vivo was further assessed in pancreatectomized miR-132/ and
control mice.
Results: Partial pancreatectomy signiﬁcantly increased the number of BrdUþ/insulinþ islet cells. Microarray proﬁling revealed that 14 miRNAs,
including miR-132 and -141, were signiﬁcantly upregulated in the LCM islets of the partially pancreatectomized mice compared to the LCM islets
of the control mice. In the same comparison, miR-760 was the only downregulated miRNA. The changed expression of these miRNAs in the islets
of the partially pancreatectomized mice was conﬁrmed by RT-PCR only in the case of miR-132 and -141. Based on previous knowledge of its
function, we focused our attention on miR-132. Downregulation of miR-132 reduced the proliferation of MIN6 cells while enhancing the levels of
pro-apoptotic cleaved caspase-9. The opposite was observed in miR-132 overexpressing MIN6 cells. Microarray proﬁling, RT-PCR, and
immunoblotting of the latter cells demonstrated their downregulated expression of Pten with concomitant increased levels of pro-proliferative
factors phospho-Akt and phospho-Creb and inactivation of pro-apoptotic Foxo3a via its phosphorylation. Downregulation of Pten was further
conﬁrmed in the LCM islets of pancreatectomized mice compared to the sham-operated mice. Moreover, overexpression of miR-132
correlated with increased proliferation of EndoC-bH1 cells. The regeneration of beta cells following partial pancreatectomy was lower in the miR-
132/212/ mice than the control littermates.
Conclusions: This study provides compelling evidence about the critical role of miR-132 for the regeneration of mouse islet beta cells through
the downregulation of its target Pten. Hence, the miR-132/Pten/Akt/Foxo3 signaling pathway may represent a suitable target to enhance beta cell
mass.
 2019 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. INTRODUCTION
MiRNAs belong to the class of short non-coding RNAs that regulate
gene expression by annealing to 30-untranslated region sequences in
target mRNAs and inducing their post-transcriptional repression [1].
The functional importance of miRNAs has been extensively investi-
gated in recent years and their altered expression has been implicated
in a wide range of diseases, including cancer [2], cardiovascular
disease [3,4], and diabetes [5,6]. Increasing evidence indicates that
miRNA-dependent post-transcriptional gene silencing is implicated in
regulating beta cell function and can potentially be linked to the
development of diabetes [7]. In pancreatic beta cells, the changed
expression of miRNAs correlates with profound impairment of insulin
secretion [8]. RNA sequencing of human islets detected 346 miRNAs,
including 40 that were enriched compared to other tissues [9]. miR-
375 is the most highly expressed miRNA in human and mouse
pancreatic islets. Its downregulation inhibits pancreatic islet develop-
ment in Xenopus laevis [10], while its global inactivation in mice leads
to decreased beta cell mass and ultimately diabetes [11,12]. MiR-132
also plays a key role in beta cell function. Its expression is altered in
different mouse models of type 2 diabetes (T2D) [13e15], and its
overexpression is correlated with improved glucose-stimulated insulin
release from dissociated rat islet cells [15] and enhanced beta cell
proliferation and survival [14e16]. In PC12 cells, another endocrine
cell model, miR-132 controls cell survival via direct regulation of Pten,
Foxo3a, and p300 signaling [17]. However, in pancreatic islets, the
functional relevance of miR-132 in vivo and its downstream targets
remain unknown and its involvement in beta cell regeneration in vivo
has not been investigated. To identify the major miRNAs and their
downstream targets involved in beta cell proliferation, we analyzed the
proﬁle of miRNAs differentially expressed in laser capture micro-
dissected (LCM) islets of partially pancreatectomized mice compared
to LCM islets of sham-operated mice.
2. METHODS
2.1. Mice
The miR-132/212/ mice were a gift from K. Chowdhury and was
generated by homologous recombination of the genomic region
encoding pre-miR132 and pre-miR-212 [18]. The miR-132/212/
mice used in this study had been backcrossed into the C57Bl/6N
background for at least seven generations. All animal protocols were
approved by the institutional animal care and use committee at the
Faculty of Medicine of TU Dresden and all experiments were conducted
in accordance with relevant guidelines and regulations.
2.2. Mouse partial pancreatectomy
Thirteen to 19 week-old male C57Bl/6N mice with body weights of
28e34 g were subjected to a 75% partial pancreatectomy (3 mice) or
sham operated (4 mice) as described [19], except for anesthesia,
which was administered using a small rodents’ anesthesia unit (Har-
vard Apparatus Ltd., Holliston, MA, USA) for mask inhalation of iso-
ﬂurane (Baxter Deutschland GmbH, Unterschleibheim, Germany) at a
concentration of 4.5e5% for induction and 2e2.5% for maintenance
of anesthesia with an airﬂow rate of 200 ml/min. For perioperative
analgesia, buprenorphine (0.05 mg/kg bodyweight) was administered
subcutaneously. At the end of surgery, Alzet 1007D mini-osmotic
pumps (Alza, Cupertino, CA, USA) were implanted intraperitoneally to
deliver 50 mg ml1 BrdU (SigmaeAldrich, St. Louis, MO, USA) in 50%
DMSO at a rate of 0.5 ml h1 for 7 days. Blood glucose levels were
measured daily with a Glucotrend glucometer (Roche Diagnostics,MOLECULAR METABOLISM 31 (2020) 150e162  2019 The Author(s). Published by Elsevier GmbH. This is an ope
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was performed on 4 wild-type mice for RNA extraction from LCM islets
isolation and validation of miRNA expression by RT-PCR. Furthermore,
12 wild-type and 12 miR-132/212/ mice were equally divided in
four groups, each consisting of 6 animals, for sham or partial
pancreatectomy as previously described. Pancreatic tissue from these
mice was collected 7 days after surgery and processed for BrdU la-
beling as follows.
2.3. BrdU staining of pancreatic tissue sections
The pancreatectomized and sham-operated mice were anesthetized 7
days post-surgery as described. After ﬁxation by intracardial perfusion
with 4% PFA, the pancreas was removed, ﬁxed overnight in 10%
neutral formalin, embedded in parafﬁn, and cut into 10-mm thin serial
sections. Immunostaining was performed as described in [19].
2.4. Intraperitoneal glucose tolerance test (IpGTT)
IpGTTs were conducted two days before surgery and six days after
surgery to assess differences between the wild-type and mutant mice
and between the pancreatectomized and sham-operated animals.
After an overnight fast of 10 h, the mice were injected with 2 g/kg body
weight of 20% glucose solution. Glucose levels were measured in
blood samples collected from the tail veins at 0, 15, 30, 60, 120, and
180 min after glucose injection.
2.5. Laser capture microdissection of islets after partial
pancreatectomy
The mice were sacriﬁced seven days post-surgery. The remnant
pancreas was excised for serial sectioning (40 sections/mouse) and
staining with cresyl violet to locate the islets. Adjacent unstained
sections were then used to the count BrdUþ cells prior to islet core
excision by laser capture microdissection with a PALM MicroBeam
Laser Capture System (Zeiss, Feldbach, Switzerland).
2.6. MicroRNA proﬁling of LCM islets with microarrays and RT-PCR
RNA was isolated from the LCM islets and 100 ng was used for the
microarray analysis of differentially expressed microRNAs. The hy-
bridization was performed using Agilent Mouse miRNA Microarray
8  15 K 019,119, which covered 3p of 589 distinct microRNAs
targets. Expression of the selected microRNAs was further tested by
RT-PCR using RNA extracted from an independent set of LCM islets
from another group of C57Bl/6N pancreatectomized and sham-
operated mice. cDNA obtained from the reverse transcription of
LCM-isolated RNA was used as template for real-time PCR analysis
using miScript primer assays in combination with a miScript SYBR
Green PCR Kit (Qiagen, Hilden, Germany).
2.7. Gene expression analysis of LCM islets using microarrays
RNA was isolated from the LCM islets of three C57Bl/6N pancrea-
tectomized and two sham-operated mice using an RNeasy Mini Kit
from Qiagen as previously described. The RNA quality was assessed
using an RNA 6000 Pico Kit from Agilent. A total of 100 ng RNA per
condition were used for hybridization using the Affymetrix GeneChip
Mouse Genome 430 2.0 Array according to the manufacturer’s in-
structions. The gene expression signals were normalized for the b-
actin levels and analyzed with ANOVA for statistically signiﬁcant
differences.
2.8. Cell culture
Mouse MIN6 cells, a gift from Dr. Jun-ichi Miyazaki (Osaka University,
Osaka, Japan), were cultured as described [20] in 25 mmol/L glucosen access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 151
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Waltham, MA, USA) and supplemented with 15% fetal bovine serum
(Gibco), 100 U/mL penicillin, 100 U/mL streptomycin (SigmaeAldrich),
and 70 mM b-mercaptoethanol (SigmaeAldrich) at 37 C in a hu-
midiﬁed atmosphere with 5% CO2. EndoC-bH1 cells were cultured as
described in [21]. HEK293T cells were cultured in 25 mmol/L glucose
Dulbecco’s modiﬁed Eagle’s medium (Gibco) and supplemented with
10% fetal bovine serum (Gibco), 100 U/mL penicillin, 100 U/mL
streptomycin (SigmaeAldrich), and 0.1 mM non-essential amino acids
(Gibco) at 37 C in a humidiﬁed atmosphere with 5% CO2.
2.9. Cloning of miR-132 in pacAd5 shuttle vector
An adenovirus vector for miR-132 overexpression was generated using
the RAPAdmiRNA Adenoviral Expression System (Cell Biolabs, San Diego,
CA, USA). Following the kit’s instructions, the mmu-miR-132 precursor
sequence, obtained from https://www.miRBase.org (GGTAACAGTCTA
CAGCCATGGTCGCCC), was PCR ampliﬁed from mouse genomic DNA
including aw100 bp ﬂanking region on each side (forward: 50-TCGAG-
GATCCTCCCTGTGGGTTGCGGTGGG-30; reverse: 50-TCGAGCTAGCA-
CATCGAATGTTGCGTCGCCGC-30) and then cloned into the human b-
globin Intron of the kit’s pacAd5-miR-GFP-Puro vector via BamHI/NheI
digestion. This human b-globin intron containing mmu-miR-132 pre-
cursor was then subcloned into the kit’s pacAd5-CMV-eGFP vector via
PCR ampliﬁcation (forward: 50-TGCAACCGGTGCCAGAACACAGGTACA-
CATAT-30; reverse:50-TGCAACCGGTCGTGCTTTGCCAAAGTGATG-30) and
AgeI digestion to obtain a, miR-132 overexpressing shuttle vector with a
CMV promoter. The empty pacAd5-CMV-eGFP vector was used to pro-
duce a control virus.
2.10. Adenovirus production in HEK293T cells
The adenoviral backbone vector pacAd5-9.2-100 from the RAPAd
miRNA Adenoviral Expression System (Cell Biolabs) and both shuttle
vectors pacAd5-CMV-eGFP and pacAd5-CMV-mir132-eGFP were PacI
linearized and co-transfected into HEK293T cells using X-tremeGENE 9
DNA transfection reagent (Roche). Adenoviral particles collected from
the medium were aliquoted and stored at 80 C. Virus titers were
determined with an Adeno-X Rapid Titer Kit (Clontech, Mountain View,
CA, USA). All steps were carried out according to the manufacturer’s
instructions.
2.11. BrdU labeling of miR-132 silenced or overexpressing culture
cells
For the silencing of the miR-132 in MIN6 cells, the following siRNA
oligo was used: 50-CGACCAUGGCUGUAGACUGUUACC-3 (Riboxx,
Radebeul, Germany). A scrambled siRNA oligo was used as a control.
The MIN6 cells were transfected in a 6-well plate with 100 nM miR-
132 or the scrambled siRNA oligos using Dharmafect4 (Thermo Fisher
Scientiﬁc) as a transfection reagent on day 1 after seeding. On day 4,
after siRNA oligo removal, the cells were either harvested for Western
blotting or further incubated with BrdU (Roche, Basel, Switzerland) for
8 h and then ﬁxed with 4% paraformaldehyde (PFA). For miR-132
overexpression, the MIN6 and EndoC-bH1 cells were transduced for
16 or 4 h, respectively, with CMV-eGFP or CMV-miR132-eGFP (MOI:
6.4  103). On day 4, miR-132 overexpressing MIN6 cells were also
incubated with BrdU for 8 h and then ﬁxed with 4% PFA. After
transduction, the EndoC-bH1 cells were incubated for 48 h in medium
with DMSO (1/10,000) plus or minus 10 mM harmine (SigmaeAldrich)
and then for additional 72 h with BrdU before ﬁxation with 4% PFA. The
cells were then stained with BrdU according to the manufacturer’s
instructions. This protocol was also used to immunostain the EndoC-
bH1 cells for phosphohistone H3 (Cell Signaling, Danvers, MA, USA).152 MOLECULAR METABOLISM 31 (2020) 150e162  2019 The Author(s). Published by Elsevier GmbH. T2.12. Insulin secretion
The MIN6 cells were transfected on day 1 with Mock or pEZX-miR-132
plasmid expressing the mature form of miR-132 from a commercial
vector (Gene Copoeia, Rockville, MD, USA). Two days post-
transfection, the cells were incubated in growth serum-free media
with or without 0.5 mM palmitate/0.5% BSA for 24 h. On day 3 post-
transfection, the cells were pre-incubated for 1 h at 37 C in buffer
containing 120 mmol/l NaCl, 5 mmol/l KCl, 2 mmol/l CaCl2, 1 mmol/l
MgCl2, 24 mmol/l NaHCO3, 0.1% (wt./vol.) BSA, 15 mmol/l HEPES,
and pH 7.4 with 0 mM glucose (resting media). After pre-incubation,
the cells were re-incubated either in resting or stimulating media
(25 mM glucose) for a 1.5 h. The media were collected and the cells
were harvested and lysed in acidiﬁed ethanol (75% [vol./vol.] ethanol
and 0.55% [vol./vol.] HCl). The amount of intracellular and released
insulin was measured using a radioimmunoassay (Merck Millipore,
Billerica, MA, USA).
2.13. Caspase-3/7 assay
The MIN6 cells transduced either with CMV-eGFP or CMV-miR132-
eGFP were cultured in a 12-well plate. On day 3, the cells were
incubated in fresh media with or without 1 mM staurosporine for 12 h.
On day 4, the cells were harvested and lysed using reagents from a
Caspase-Glo 3/7 assay (Promega, Madison, WI, USA). The cleavage of
non-ﬂuorescent rhodamine 110 bis-(N-CBZ-l-aspartyl-l-glutamyl-l-
valyl-aspartic acid amide) (Z-DEVD-R110) substrate and its conversion
to ﬂuorescent rhodamine 110, which was proportional to the caspase-
3/7 activity, was quantiﬁed according to the manufacturer’s
instructions.
2.14. Cell extraction and immunoblotting
The MIN6 cells were harvested at 4 C in RIPA buffer (50 mM Tris$HCl,
pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 0.5% sodium
deoxycholate, and protease inhibitor mixture; SigmaeAldrich) for total
protein extraction. Insoluble material was removed by centrifugation.
Aliquots of 20 mg were separated by SDS-PAGE as previously
described [18]. The source, species, and dilutions of antibodies used
for immunoblotting are listed in ESM Table 1.
2.15. RNA isolation from MIN6 and EndoC-BH1 cells for microRNA
measurement
The cells were harvested after washing them once in Dulbecco’s PBS
(SigmaeAldrich) by scraping and pelleting them via centrifugation at
3,000g at 4 C for 5 min. The cell pellets were immediately stored
at 80 C. MiRNA isolation was performed with a mirVana miRNA
Isolation Kit (Ambion, Foster City, CA, USA) according to the manu-
facturer’s instructions. Both the total RNA and microRNA-enriched
fractions were isolated. RNA concentrations were measured with a
NanoDrop ND-1000 spectrophotometer (PEQLAB/VWR, Darmstadt,
Germany). The samples were stored at 80 C.
2.16. TaqMan microRNA assay
Reverse transcription of 15 ng miRNA/reaction of the miRNA-enriched
fraction into cDNA was performed with a TaqMan MicroRNA Reverse
Transcription Kit (Applied Biosystems) using the miR-132-speciﬁc or
the U6 snRNA-speciﬁc stem-looped RT primer of the TaqMan Micro-
RNA Assay hsa-miR-132 (Applied Biosystems, Cat.# 4427975, Assay#
000457; Thermo Fisher Scientiﬁc, Waltham, MA, USA) or the TaqMan
Micro RNA Control Assay U6 snRNA (Applied Biosystems, Cat #
4427975, Assay# 001973; Thermo Fisher Scientiﬁc, Waltham, MA,
USA). Both transcriptions were conducted for each sample. Real-time
PCR was then performed with TaqMan Universal PCR Master Mixhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(Applied Biosystems/Thermo Fisher Scientiﬁc, Waltham, MA, USA) on
an Aria MX Real-Time PCR System (Agilent Technologies) using the
small RNA-speciﬁc primer mixes of the previously described TaqMan
assays. All of the steps were carried out according to the manufac-
turer’s instructions.
2.17. Real-time PCR
The cDNA samples were obtained by reverse transcription of 1 mg total
RNA using M-MLV Reverse Transcriptase (Promega). Quantitative real-
time PCR was then performed with GoTaq qPCR Master Mix (Promega)
according to the manufacturer’s instructions using the oligonucleotides
listed in ESM Table 2.
2.18. Dual luciferase reporter assay
Analysis of the TargetScan Mouse 7.2 database (http://www.targetscan.
org) to predict the miR-132 targets revealed the presence in Mapk1 and
Pten of 4 and 6 highly conserved regions for pairing with miR-132/212,
respectively. Of these regions, 2 in Mapk1 and 3 in Pten were speciﬁc
for miR-132 only. Oligonucleotides encompassing the sequences con-




AAACGGAAGCTTGGCAATCC-30) or a control scrambled sequence (50-
CCTTCAACGGCCTTCATGGCTTGGGCACAAGGAGAAGGGCGAG GTATGG
CTTGGACAACGGAAGCTTGGCAATCC-30) were subcloned into the XhoI/D
A B
Figure 1: Quantiﬁcation of BrdUD cells in islets of partially pancreatectomized mice
excised 1 week after partial pancreatectomy stained with cresyl violet to reveal the islet co
the cell nuclei and replicating cells, respectively. (C) Enrichment of beta cell-speciﬁc mar
Percentage of BrdUþ cells in the islet cores. The analysis included 7 mice, of which 4 were
for BrdUþ cells. *p < 0.05.
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psiCHECK2 (Promega). The dual luciferase activity assay was performed
according to the manufacturer’s instructions.
2.19. Statistical analyses
The statistical analyses were performed using unpaired Student’s t-
test unless otherwise stated. The results are presented as mean SE
unless otherwise stated. A value of p  0.05 was considered signif-
icant. Error bars show the standard deviations from at least three in-
dependent experiments unless otherwise stated. Histograms were
prepared with Microsoft Excel (Microsoft, Redmond, WA, USA) or
GraphPad Prism.
3. RESULTS
3.1. MiR-132 is upregulated in proliferating islet cells of
pancreatectomized mice
To identify the key miRNAs involved in beta cell proliferation, we used
partially pancreatectomized mice (n ¼ 3) as a model for beta cell
regeneration (Figure 1A). The removal of 70e80% of the pancreas is a
well-established procedure for inducing the replication of beta cells in
the remaining pancreas [19,22]. Proliferating cells were stained with
25 mg/h BrdU continuously delivered by an osmotic mini-pump
implanted in the abdomen at the time of partial pancreatectomy.
This approach ensures the labeling of every dividing cell [19]. As
controls, 4 mice were similarly implanted with an osmotic mini-pumpC
. (A) Overview of the experimental design. (B) A tissue section of the remnant pancreas
re. The tissue was labeled with DAPI (green) and anti-BrdU antibodies (black) to detect
kers shown by Q-PCR of mRNA extracted from laser capture microdissected islets. (D)
sham-operated and 3 were partially pancreatectomized. 40 slices/group were counted
n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 153
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post-surgery, all of the mice were sacriﬁced. Their remnant pancreas
were excised for serial sectioning (40 sections/mouse) and staining
with cresyl violet to locate the islets. Adjacent unstained sections were
then used to count BrdUþ cells in the islet cores, which in rodents
consist mainly of beta cells [23] (Figure 1B) prior to islet core excision
by laser capture microdissection (LCM). Accordingly, total RNA
extracted from the LCM islets was enriched for beta cell-speciﬁc
transcripts Ins1, Ins2, Pdx1, and IAPP (Figure 1C). As expected, in
the partially pancreatectomized mice, the fraction of islet core BrdUþ
cells/total islet core cells determined by nuclear counting was signif-
icantly higher than in the sham-operated mice (Figure 1D). The RNA
extracted from the LCM islet cores was then proﬁled using micro-
arrays. Fourteen miRNAs were differently expressed (cut-off values:
p  0.05; FC  1.5) in the islet cores of the partially pancreatecto-
mized mice compared to the sham-operated mice (Table 1). All of the
miRNAs were upregulated, except miR-760, which was reduced by
2.28-fold. The expression levels of all 14 differentially expressed
miRNAs were further quantiﬁed by real-time PCR (RT-PCR) and the
signiﬁcantly changed expression of miR-132 and miR-141 was vali-
dated (ESM Table 3). Given the role of miR-132 in the replication
in vitro of primary islet cells [15] and other cell types, including glioma
cells [24] and epidermal keratinocytes [25], we focused on its potential
involvement and mode of action in the regulation of beta cell
proliferation.
3.2. MiR-132 promotes the proliferation and survival of mouse
insulinoma MIN6 cells
We ﬁrst downregulated the miR-132 expression in the mouse insuli-
noma MIN6 cells using an anti-microRNA approach. Reduced
expression of miR-132 by 90% (n¼ 3, Figure 2A), as assessed by RT-
PCR, correlated with a modest yet signiﬁcant reduction
(89%  6.47%) in the percentage of the BrdUþ cells relative to the
control cells (100%  8.16%, n ¼ 6, p-value ¼ 0.039) that had been
transfected with control siRNA (Figure 2BeD). MiR-132 depletion
correlated also enabled increased detection of cleaved caspase-9
(n ¼ 6; Figure 2E,F), while the levels of cleaved caspase-3 did not
signiﬁcantly change. Conversely, overexpression of miR-132 with a
bicistronic adenovirus vector also encoding for eGFP (n¼ 3. Figure 2G)
was not associated with a further increase in the proliferation of the
MIN6 cells, presumably due to their neoplastic state (n ¼ 3,Table 1 e miRNAs differentially expressed in islet cores of partially pancreatec
Systematic name p-value FC Px1 Px1
mmu-mir-205* 0.009 4.91 6.5011 12.7521
mmu-mir-132* 0.005 4.63 85.442 90.0032
mmu-mir-186* 0.016 2.5 4.0622 5.34,086
mmu-mir-129-3p* 0.022 1.99 213.55 272.406
mmu-mir-690* 0.03 1.79 49.413 48.5373
mmu-mir-130b* 0.014 1.77 42.937 40.5664
mmu-mir-300* 0.045 1.77 2.9997 4.06448
mmu-mir-598* 0.049 1.75 18.357 22.9878
mmu-mir-431* 0.013 1.65 23.393 27.3673
mmu-mir-329* 0.035 1.64 25.756 29.392
mmu-mir-154* 0.029 1.63 19.404 19.675
mmu-mir-141* 0.04 1.59 878.04 970.708
mmu-mir-200c* 0.039 1.58 976.04 997.919
mmu-mir-375 0.107 1.48 6291.99 7241.707
mmu-mir-760* 0.041 - 2.28 12.088 13.0156
FC: Fold change.
Px (1e3): 3 Pancreatectomized mice S; (1e4): 4 control sham-operated mice.
* p<0.05.
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reduced levels of pro- and cleaved caspase-9 (n ¼ 6, Figure 2K, L),
consistent with the anti-apoptotic role of the latter. The anti-apoptotic
role of miR-132 was corroborated by reduced staurosporine-induced
apoptosis in cells overexpressing miR-132 (Figure 2M), consistent
with the decreased levels of cleaved caspase-9 [26] observed in these
cells (Figure 2K). The miR-132-induced decrease in pro- and cleaved
caspase-9 expression was likely post-transcriptional, since in the miR-
132 overexpressing cells, the levels of procaspase-9 mRNA, as
measured by RT-PCR, did not signiﬁcantly change relative to the
control cells (Figure 2N).
We further found that in the MIN6 cells, overexpression of miR-132
neither affected glucose-stimulated insulin secretion nor prevented its
35% reduction upon treatment of the cells with 0.5 mM palmitate for
24 h (ESM Fig. 1).
3.3. MiR-132 promotes the proliferation of human EndoC-bH1
cells
To further assess its role in beta cell proliferation, we overexpressed
miR-132 together with eGFP in human EndoC-bH1 cells, which pro-
liferate less than MIN6 cells (Figure 3). The miR-132 overexpression in
these cells correlated with aw2-fold (118%, p < 0.001) increase in
the number of BrdUþ and GFPþ cells (Figure 3A,B, and E) without a
reduction in the number of cells left on the coverslip 5 days after
transfection compared to GFPþ cells treated with 1.4 mM DMSO alone
for 48 h prior to BrdU labeling (p ¼ 0.262; Figure 3F). In comparison,
the known inducer of b cell proliferation harmine [27] increased the
number of BrdUþ, GFPþ cells by w3-fold (187%, p < 0.001;
Figure 3A,C, and E) without increasing the miR-132 levels as
measured by RT-PCR (Figure 3G). Treatment with 10 mM harmine in
1.4 mM DMSO for 48 h, however, also correlated with a pronounced
reduction (69%, p< 0.001) in the total number of remaining cells on
day 5 after treatment as measured with DAPI staining of the nuclei
(Figure 3F). Combination of harmine and miR-132 overexpression
further increased the number of BrdUþ and GFPþ cells by 27%
(p < 0.001) compared to harmine alone (Figure 3C,D, and E). In this
case, the number of cells remaining on day 5 was still reduced relative
to the control (49%, p < 0.001) and miR-132 overexpressing
(36%, p¼ 0.031) cells (Figure 3F). Notably, 91% of the cells treated
with harmine and transduced with miR-132 were proliferating
compared to 71% of the cells treated with harmine only, consistenttomized mice.
Px3 S1 S2 S3 S4
9.4035 1 5.34,742 2.0243 1
71.439 26.371 16.9079 22.282 8.6324
3.1434 1.7227 1.1133 1.9388 1.686
121.26 118.28 100.958 92.346 68.376
30.88 23.957 39.5096 16.126 17.206
29.545 22.405 28.2766 18.247 14.679
2.006 1.8972 1.78,003 1.8814 1
14.596 12.314 10.6534 12.703 6.3097
17.432 14.414 15.546 13.637 9.7251
19.037 17.004 16.0322 15.797 9.9605
15.306 10.545 11.4188 13.067 8.2187
655.42 566.11 672.314 515.55 318.15
672.69 608.97 681.16 530.91 361.34
4643.13 4778.29 4398.79 4440.34 2461.28
4.6472 12.305 37.794 19.394 17.248









Figure 2: MiR-132 regulates the proliferation and caspase levels in MIN6 cells. (A) Levels of miR-132 in MIN6 cells treated with control (white bar) or miR-132 (black bar)
siRNA as determined by RT-PCR. (B-C) Representative confocal images of BrdUþ cells (green) in MIN6 cells treated with control (B) or miR-132 (C) siRNA. (D) Number of BrdUþ in
control vs miR-132 depleted MIN6 cells counted from images as in (B-C). (E) Representative immunoblots for pro- and cleaved caspase-9, cleaved caspase-3, and g-tubulin as
loading controls in extracts of MIN6 cells treated with control or miR-132 siRNA. (F) Densitometric quantiﬁcation of immunoblots as in (E). White bars: control siRNA-treated cells;
black bars: miR-132 siRNA-treated cells. (G) Expression levels of miR-132 in MIN6 cells transduced with adenovirus vectors for the co-expression of miR-132 and eGFP (black bar)
or eGFP alone (white bar) as detected by RT-PCR. (H-I) Representative confocal images of BrdUþ (red) and eGFPþ (green) MIN6 cells transduced with adenovirus vectors for the co-
expression of miR-132 and eGFP (i) or eGFP alone. Nuclei were detected with DAPI (blue). (J) Number of BrdUþ and GFPþ cells normalized to GFPþ cells in MIN6 cells transduced
with eGFP (white bars) or miR-132 and eGFP (black bars) counted from images as in (H-I). (K) Representative immunoblots for pro- and cleaved caspase-9, cleaved caspase-3, and
g-tubulin as loading controls in extracts of MIN6 cells transduced with adenovirus vectors for the co-expression of miR-132 and eGFP or eGFP alone. (L) Densitometric quan-
tiﬁcation of immunoblots as in (K). (M) caspase-3/7 enzymatic activity was assayed by measuring the cleavage of Z-DEVD-R110 substrate via spectrophotometry as described in
the materials and methods section. (N) Expression of procaspase-9 mRNA in MIN6 cells overexpressing miR-132 (white bar) and eGFP (black bar) as measured by RT-PCR. n ¼ 3.with miR-132’s role in promoting cell proliferation. Intriguingly, how-
ever, among the cells treated with harmine and overexpressing miR-
132, as assessed by being GFPþ, the number of cells immunostained
for phosphohistone H3 (pHH3), a marker of the late G2 and M phases,
was reduced 3-fold compared to the DMSO-treated cells (ESM Fig. 2).
3.4. miR-132 regulates Pten signaling in MIN6 cells and in islets
from pancreatectomized mice
Next, we assessed the downstream targets of miR-132 in MIN6 cells.
Microarray gene expression analysis of miR-132 overexpressing MIN6
cells identiﬁed 345 unique differentially expressed genes (cut-off
values: p < 0.05, FC  1.5), with 194 (56.2%) as being down-
regulated and 151 (43.8%) upregulated (Figure 4A and ESM Table 4).
Using the TargetScan Mouse 7.2 database, 31 of the down- and 2 of
the upregulated genes were predicted to contain highly conservedMOLECULAR METABOLISM 31 (2020) 150e162  2019 The Author(s). Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.combinding sites for miR-132 (Figure 4A and ESM Table 5). Further
evaluation of the regulated genes with Ingenuity Pathway Analysis
revealed 8 regulated pathways (Figure 4B and ESM Table 6), which
included 26 of the 345 differentially expressed genes, mostly related to
cell proliferation and survival (Figure 4C and ESM Table 7). Among
these 26 genes, the top 10 most represented genes in the 8 signaling
pathways were further selected for validation of their mRNA levels by
RT-PCR. As a control, we also assessed the mRNA expression levels of
Rasa1, an established target of miR-132 [28]. As shown in Figures 4D
and 6 out of 10 of the selected genes, namely Mapk1/Erk2, Pten, Nras,
Pik3r1, Gnb1, and Gnb5, were conﬁrmed to be downregulated upon
miR-132 overexpression. Among those genes, Mapk1 and Pten were
also among the 31 predicted targets for miR-132 binding (ESM
Table 5). Notably, Mapk1, also known as Erk2, is a serine-threonine






Figure 3: Effect of miR-132 on beta cell proliferation in EndoC-bH1 cells. (AeD) Representative confocal images of BrdUþ (red) and eGFPþ (green) in EndoC-bH1 cells
transduced with adenovirus vectors for control eGFP (A and C) or miR-132-eGFP (B and D) expression either in 1.4 mM DMSO (A and B) or 10 mM harmine (C and D). Nuclei were
detected with DAPI (blue). (E) BrdUþ and GFPþ EndoC-bH1 cells normalized to GFPþ cells in control or miR-132 overexpressing cells treated as described in (A-D). (F) Mean
number of DAPIþ cells of EndoC-bH1 cells/ﬁeld transduced as described in (AeD). White bars: cells transduced with CMV-eGFP adenovirus vector; black bars: cells transduced
with CMV-miR-132/eGFP adenovirus vector. (G) Relative miR-132 level in EndoC-bH1 cells treated with 1.4 mM DMSO or 10 mM harmine. Data shown in (AeD) were collected
from 15 to 20 images with 1,000e4,000 cells for each condition. Scale bars in (AeD) ¼ 50 mm *p < 0.05, **p < 0.01, **p < 0.001.
Original ArticlePten and both genes play a critical role in the control of cell prolifer-
ation and survival [29,30]. We then used dual luciferase assays to test
whether miR-132-mediated downregulation of Mapk1 and Pten occurs
through a direct binding of miR-132 to their mRNA 30-UTR. As shown
in Figure 4E, these analyses indicated that miR-132 overexpression
inhibited the activity of Renilla luciferase constructs bearing the seed
regions of either Mapk1 or Pten by 61% and 46%, respectively. We
further veriﬁed whether the islet expression of the miR-132 target Pten
was altered upon pancreatectomy. In the LCM islets of the pancrea-
tectomized mice, the levels of Pten mRNA were reduced (p ¼ 0.012)
compared to the LCM islets of the sham-operated mice (ESM Fig. 3A).
Similar to the Min6 cells, the expression of Nras and Pik3r1 was also
reduced in the LCM islets of the pancreatectomized mice. Moreover,
this analysis revealed that the upregulation in the LCM islets of the
pancreatectomized mice of genes implicated in the regulation of cell
proliferation and the cell cycle such as cyclins d1, d2, and stathmin1
(Stmn1) (ESM Fig. 3b).156 MOLECULAR METABOLISM 31 (2020) 150e162  2019 The Author(s). Published by Elsevier GmbH. T3.5. MiR-132 regulates Pten/Akt/Foxo3 signaling in MIN6 cells
Next, we tested whether the overexpression of miR-132 affected the
protein levels of Pten andMapk1/Erk2. Immunoblotting of the MIN6 cells
transduced with a miR-132/eGFP viral vector conﬁrmed the down-
regulation of Pten in parallel with the upregulation of its targets Akt and
phospho-Akt (S473) (Figure 5A,B), while the Akt mRNA levels were
unchanged (ESM Fig. 4). Furthermore, the levels of the Akt substrate
Creb and phospho-Creb (S133) were unchanged, but the phospho-Creb/
Creb ratio increased. Likewise, the overexpression of miR-132 corre-
lated with reduced expression of Mapk1/Erk2, phospho-Mapk1/Erk2,
and Rasa1/RasGAP, but not Erk1 and phospho-Erk1 (Figure 5C,D). As
the downregulation of miR-132 correlated with elevated cleaved
caspase-9 levels, we further tested whether its overexpression affected
the expression of Foxo3a, a key mediator of apoptosis. Immunoblotting
of miR-132 overexpressing cells for Foxo3a showed that its inhibitory
phosphorylation increased (Figure 5EeF), while its mRNA (ESM Fig. 4)




Figure 4: Identiﬁcation and validation of miR-132 target genes in MIN6 cells. (A) Venn diagram showing the number of down- and upregulated genes in MIN6 cells
transduced with CMV-miR-132/eGFP adenovirus vector compared to MIN6 cells transduced with CMV-eGFP adenovirus vector and their overlap with predicted highly conserved
murine mouse targets of miR-132. (B) Ingenuity Pathway Analysis of signiﬁcantly altered pathways in MIN6 cells overexpressing miR-132 and eGFP compared to MIN6 cells
overexpressing eGFP alone. (C) Heat map of the 26 (red vertical bar: cluster of downregulated genes; blue vertical bar: cluster of upregulated genes) among the 345 differentially
expressed genes included in the 8 regulated pathways indicated in (B) and related to cell proliferation and survival in MIN6 cells overexpressing miR-132 and eGFP relative to MIN6
cells overexpressing eGFP alone. The brightest shades of yellow and blue reﬂect the higher and lower expression levels of a given gene as indicated in the top horizontal bar. The
results are from 3 independent microarray analyses. (D) Validation by RT-PCR of the expression levels of the top 10 most represented genes in the 8 signaling pathways shown in
(B) and among the 26 regulated genes shown in (C). White bars: expression in MIN6 cells overexpressing eGFP alone; black bars: expression in MIN6 cells overexpressing miR-132
and eGFP. (E) Min6 cells were co-transfected with 1.5 ug of bicistronic vector psiCHECK-2 in which Pten-30-UTR or Mapk1-30-UTR were inserted downstream of the Renilla
translational stop codon along with 100 nM of either control or miR-132 mimic oligonucleotide. Co-expressed ﬁreﬂy luciferase was used for the normalization of Renilla luciferase
expression, and the luciferase activity of the control was set as 100% The data represent mean  standard error from 3 separate experiments. *p < 0.05, **p < 0.01,
**p < 0.001. (B) The signiﬁcance was assessed using the BenjaminieHochberg test.3.6. Deletion of miR-132/212 impairs islet beta cell proliferation in
pancreatectomized mice
As MIN6 and EndoC-bH1 are tumor cell lines, their increased prolif-
eration upon miR-132 overexpression does not necessary imply that
miR-132 fosters the proliferation of primary beta cells in vivo. In
addition, the cell cycle machinery of these insulinoma cells might be
affected by adenoviral transduction. To verify whether miR-132 posi-
tively affects beta cell regeneration in vivo, we measured the beta cell
proliferation in the partially pancreatectomized or sham-operated miR-
132/212/ mice and the control littermates (6 mice/group). Intra-
peritoneal glucose tolerance tests prior and 6 days after surgery
showed no difference between the control and miR-132/212/ mice
(Figure 6A,B). Daily blood glucose measurements, in particular,
demonstrated a comparable modest decrease in glycemia in the
partially pancreatectomized wild-type and miR-132/212/ mice
relative to the sham-operated mice on the ﬁrst day post-surgery,
followed by a complete normalization of glycemia by the end of the
1-week-long protocol (ESM Fig. 5). Seven days after surgery, the mice
were sacriﬁced, the remnant pancreas excised, and the BrdUþ/
insulinþ beta cells were counted (Figure 6CeF and ESM Table 8). AsMOLECULAR METABOLISM 31 (2020) 150e162  2019 The Author(s). Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comassessed by immunostaining for insulin, the average number of beta
cells/islet of the wild-type (31.9 beta cells/islet) and miR-132/212/
(31.7 beta cells/islet) partially pancreatectomized mice was increased
relative to their sham-operated counterparts (wild-type: 23.8 beta
cells/islet; miR-132/212/: 26.8 beta cells/islet). Likewise, the
number BrdUþ insulinþ beta cells increased in both groups of partially
pancreatectomized mice compared to the sham-operated mice
(Figure 6G, ESM Table 8). However, in the partially pancreatectomized
miR-132/212/ mice, there were fewer BrdUþ/insulinþ cells than in
the partially pancreatectomized wild-type mice (Figure 6G and ESM
Table 8). These data provide conclusive evidence that the miR-132/
212 cluster, and conceivablymiRNA-132 alone (see discussion), exerts
a positive role on the regeneration of mouse beta cells in vivo
(Figure 7).
4. DISCUSSION
MiR-132 is known to control many cellular processes in various tis-
sues, including neuronal morphogenesis and the regulation of circa-
dian rhythm. MiR-132 altered expression correlates with severaln access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 157
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Figure 5: Validation of gene proﬁling data in MIN6 cells overexpressing miR132. (A, C, and E) Representative immunoblots for the indicated proteins in cell extracts of MIN6
cells overexpressing miR-132 and eGFP or eGFP alone. (B, D, and F) Densitometric quantiﬁcation of the indicated proteins as detected by immunblots in (A), (C), and (E),
respectively. Data are from 6 independent experiments. *p < 0.05, **p < 0.01, **p < 0.001.
Original Articleneurological disorders, such as Alzheimer’s and Huntington’s diseases
[31]. Thus, most of our knowledge regarding miR-132 regulation and
biological functions emerged from studies on neural cells, while less is
known about the downstream targets of miR-132 in pancreatic beta
cells. MiR-132 and miR-212 have identical seed sequences but very
few targets in common [32]. In this study, we identiﬁed miR-132 as
one of the mostly upregulated miRNAs with a 5-fold expression change
in RNA extracted from LCM islets of partially pancreatectomized mice,
a condition that induces beta cell proliferation. Moreover, analysis of
mRNAs for well-established pancreatic islet or exocrine cell-speciﬁc
markers showed a clear enrichment in our islet extracts of beta cell
speciﬁc genes. The microarray analysis did not reveal changes in miR-
212 expression although it was arrayed on the chip. Whether this was
due to its lower expression than miR-132, as shown previously in rat
insulinoma INS-1 cells [33], cannot be excluded. Notably, the levels of
miRNAs from the same cluster can differ due to post-transcriptional
mechanisms [34]. Moreover, although miR-132 and miR-212 share
the same seed sequence, they differ in their 3p sequence. This non-
seed region plays an important role in the selection of target mRNAs
and on the regulatory features of each miRNA [32]. Furthermore, in
hippocampal neuronal cells, the overexpression of miR-132 but not
that of miR-212 correlated with the induction of genes related to cell
proliferation. As microarray analyses may yield false positives, we
further veriﬁed the increased expression of miR-132 in the islets of the
partially pancreatectomized mice by RT-PCR. This ﬁnding is in
agreement with previous data showing the elevated expression ofmiR-158 MOLECULAR METABOLISM 31 (2020) 150e162  2019 The Author(s). Published by Elsevier GmbH. T132 in different models of type 2 diabetes, including db/db, high-fat
diet-fed [15], and ob/ob mice [12,35]. Among our list of differentially
expressed miRNAs in the islets of the partially pancreatectomized
mice, miR-205 showed the greatest change (5-fold). Interestingly,
miR-205 has also been reported to be the miRNA with the highest
expression change in the hepatocytes of mice with obesity-induced
type 2 diabetes [35]. However, we did not detect signiﬁcant changes
in the expression of miR-375, which is abundant in pancreatic islets
and regulates insulin secretion and beta cell proliferation [12]. Previous
research indicated that miR-132 is highly expressed in neurons and
may regulate their differentiation [36,37]. More recent work in primary
neurons and PC12 cells suggested that miR-132 controls cell survival
by direct regulation of Pten, Foxo3a, and p300 [16]. In our study, we
conﬁrmed that the increased levels of miR-132 did not correlate with
changes in pro-caspase-9 expression, suggesting that miR-132 con-
trols apoptotic genes post-transcriptionally.
To ascertain the downstream targets of miR-132 in beta cells, we ﬁrst
investigated whether miR-132 has a proliferative role in insulinoma
MIN6 cells. MiR-132 downregulation correlated with a modest but
signiﬁcant inhibition of their proliferation. Inhibition of miR-132
expression correlated with an increase in cleaved caspase-9, while the
latter was reduced upon upregulation of miR-132. Increased expres-
sion of miR-132 was also associated with enhanced replication of
human EndoC-bH1 cells. At variance with harmine, at least in our
in vitro experimental settings, its positive effect on cell proliferation
was not associated with a detrimental impact on cell viability.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 6: Impaired pancreatic beta cell regeneration in miR-132L/L mice. (A) Expression of blood glucose levels in wild-type (blue line) and miR-132/ (red line) mice
during an intraperitoneal glucose tolerance test conducted two days before surgery. (B) Expression of blood glucose levels in wild-type and miR-132/ partially pancreatectomized
or sham-operated mice during an intraperitoneal glucose tolerance test performed six days after surgery. Sham-operated wild-type mice: blue line; partially pancreatectomized
wild-type mice: green line; sham-operated miR-132/ mice: red line; partially pancreatectomized miR-132/ mice: purple line. (CeF) Representative confocal images of
parafﬁn pancreatic sections from wild-type sham-operated (C) or partially pancreatectomized mice (E) or from miR-132/ sham-operated (D) or partially pancreatectomized (F)
mice. Sections were immunolabeled for insulin (red) and BrdU (green), while nuclei were detected with DAPI (blue). (G) Percentage of BrdUþ and insulinþ cells. White bars: wild-
type mice; black bars: miR-132/ mice. Data are from 3 independent series with two mice in each group. Up to 50 islets were counted for each mouse for a total of 250e300
islets per group.Intriguingly, miR-132/212 was also the only miRNA cluster among 250
miRNAs to be selectively upregulated in INS-1 cells and isolated rodent
and human islets in response to GLP-1, which promotes b cell pro-
liferation and neogenesis in animal models of diabetes [38]. Our data
showed a dual role of miR-132 in cell proliferation and apoptosis.
Whether the main function ofmiR-132 is to regulate cell proliferation or
survival remains a challenging question. However, evidence that 91%
of miR-132 EndoC-bH1 cells treated with harmine were BrdUþ
compared to 71% of EndoC-bH1 cells treated with harmine alone
suggested that miR-132 increases cell proliferation. Moreover, the fact
that miR-132 induced inhibition of apoptosis is less pronounced 12 h
post-staurosporine treatment than at time 0 conﬁrmed the anti-
apoptotic role of miR-132 but also suggested that the main role of
miR-132 is to promote cell proliferation.
The role of miR-132 in beta cell proliferation has already been shown
but mostly using oligonucleotides or adenovirus-mediated over-
expression of miR-132 on dispersed islets [15] or in mouse models
[16], respectively. Our studies conﬁrmed this ﬁnding and validated for
the ﬁrst time the ability of miR-132 to regulate the proliferation of b
cells in vivo following partial pancreatectomy, a well-established
surgical procedure known to induce beta cell regeneration. Such aMOLECULAR METABOLISM 31 (2020) 150e162  2019 The Author(s). Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.commodel system is of special interest for the identiﬁcation of mechanisms
for the regeneration or expansion of b cell masses in adults.
The role of miR-132 in the potentiation of GSIS has been demonstrated
in rat-dispersed islets transfected with miR-132 oligonucleotide [15].
In our study, the modulation of miR-132 expression did not show a
change in GSIS. Moreover, the overexpression of miR-132 in cells
incubated with an elevated concentration of palmitate did not improve
GSIS.
Our search for downstream targets of miR-132 indicated that the
expression of Pten was signiﬁcantly downregulated in miR-132
overexpressing cells. Furthermore, analysis of the target genes in the
LCM islets of the pancreactectomized mice further validated the
downregulation of Pten in proliferating pancreatic beta cells. The
downregulation of Pten, which was predicted to be a direct target of
miR-132, was further conﬁrmed by dual luciferase assays. Akt, the
main survival signaling pathway known to be antagonized by Pten,
was also identiﬁed and experimentally validated to be a target ofmiR-
132. P-Akt is a major activator of Foxo family proteins, which are
members of the Forkhead superfamily of winged helix transcription
factors controlling cellular metabolism [39], stress responses, DNA
damage repair, and cell death [40]. Phosphorylation of Foxo3a, inn access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 159
Figure 7: Working model illustrating the miR-132 mediated control of cell survival and proliferation of pancreatic beta cells. Islet beta cell proliferation following partial
pancreatectomy correlates with the upregulation of miR-132. MiR-132 reduces the expression of Pten, which in turn enhances Foxo3a phosphorylation. Phosphorylated Foxo3a is
sequestered in the cytosol and its transcriptional activity of pro-apoptotic genes such as caspases is reduced. Repression of Pten activity also increases the levels of P-Akt and P-
Creb and thus enhances cell proliferation. However, the involvement of Mapk/Erk signaling in miR-132-mediated beta cell proliferation is uncertain. Experimental data presented in
this manuscript and literature-based knowledge are displayed as solid and dashed lines, respectively.
Original Articleturn, promotes its cytoplasmic retention by 14-3-3 proteins, and
thereby the inhibition of its transcriptional activity [41]. In agreement
with this, we found an inverse correlation between Pten expression
and increased phosphorylation of Akt (P-Akt) and Foxo3a (P-Foxo3a),
which is consistent with increased cell proliferation and reduced
apoptosis. Of signiﬁcance was also the induced phosphorylation of
Creb, a transcription factor involved in various cellular process
including beta cell survival [42] and proliferation [43]. Inhibition of
Creb activation resulted in cell cycle arrest at the G2/M phase [44],
suggesting that P-Creb may foster the progression through the
checkpoint G2/M. Interestingly, analysis of genes differentially
expressed in the LCM islets of the pancreatectomized mice revealed
the upregulation of cell cycle regulators including cyclin d1 and d2.
Cyclin d1 induction is required during the G1 phase for the cell to
initiate DNA synthesis [45]. Among cell cycle regulators, we also
noted the upregulation of Stmn1. Notably, the upregulated expression
of Stmn1, which is a microtubule modiﬁer protein, has been shown to
shorten the G2 phase [46]. Intriguingly, immunostaining of EndoC-
bH1 cells for pHH3, a marker of both the late G2 phase and the M
phase of the cell cycle [47] revealed a reduced number of pHH3þ
cells upon the overexpression of miR-132 combined with harmine
treatment. A plausible explanation is that miR-132 facilitates the
entry into the cell cycle with a shortening of its duration.
Many miRNAs have been associated with developmental regulation of
pancreatic beta cell proliferation or differentiation (for example, miR-
375 [10], miR-7 [48], miR-124a [49], miR-24 [50], let-7a [51], miR-
26a [52], miR-184 [53], miR-195, miR-15, miR-16 [54], and miR-132
[15,37]. MiR-132 has also been found to be differentially expressed in
T2D models such as obesity-induced diabetes [37] that are associated
with increased metabolic demands on beta cells, a condition known to
promote beta cell proliferation. Constitutive deletion of miR-132 in160 MOLECULAR METABOLISM 31 (2020) 150e162  2019 The Author(s). Published by Elsevier GmbH. Tmice resulted in deﬁcient endocrine development [18], while the
restricted deletion of the miR-13/212 locus in adult hippocampus
caused a dramatic decrease in the dendrite length, arborization, and
spine density [55]. In this study, we demonstrated that the regener-
ation of beta cells in pancreatectomized miR-132/212/ mice is
reduced, conceivably through its control of the Pten/Pi3K/Akt signaling
pathway. The increased or reduced beta cell proliferation in insulinoma
cells overexpressing miR-132 or in miR-132/212/ mice, respec-
tively, cannot not be attributed to the sole action of miR-132. Indeed,
although miR-132 is highly evolutionarily conserved, studies showed
only a partial overlap of its downstream targets in mouse and human
islet alpha cells, in which miR-132 also favored proliferation [56]. This
observation raised the hypothesis that miR-132 acts in concert with
other miRNAs that regulate cell proliferation. For instance, altered
expression of miR-205, which is upregulated 5-fold in LCM islets of
partially pancreatectomized mice, has also been correlated with cell
proliferation of various cellular tissues and cell lines and with cancer
[57,58]. MiR-205, in particular, has also been shown to enhance Akt
signaling by indirectly targeting Pten and Phlpp2 [59]. Thus, the
complexity of miRNA networks with interconnected positive and
negative regulatory loops makes it difﬁcult to ascribe induced prolif-
eration to a single miRNA. Nonetheless, we have shown that the
deletion of the miR-132/212 locus alone is sufﬁcient to hamper the
regeneration of mouse beta cells in vivo.
In conclusion, we have identiﬁed miR-132 as a critical epigenetic
factor for control of beta cell replication after partial pancreatectomy.
Targeted therapies for the expansion of beta cell mass in type 1 and
type 2 diabetes are actively sought, and in this context, miR-132
appears to be a worthy candidate for consideration. Along these lines,
it would be especially interesting to determine which and how extra-
cellular signals promote its expression in beta cells.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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